Analiza de situație tbc 2016 Situația tbc la nivel mondial

MDR-TB cases among notified pulmonary TB cases

1 2 3 4 5 6 7 8 9 10 ... 21

MDR-TB cases among notified pulmonary
TB cases

290

(190–430)

360

(270–480)

TB case notifications 2014	New **	Relapse
Pulmonary, bacteriologically confirmed	7 874		1 899
Pulmonary, clinically diagnosed	2 421		356
Extrapulmonary	2 209		102

Total new and relapse	14 861
Previously treated, excluding relapses	1 045
Total cases notified	15 906

Among 14 861 new and relapse cases:

639 (4%) cases aged under 15 years; male:female ratio: 2.1

Reported cases of RR-/MDR-TB 2014	New	Retreatment	Total **
Cases tested for RR-/MDR-TB	5 751 (73%)	2 171 (64%)	7 922
Laboratory-confirmed RR-/MDR-TB cases			578
Patients started on MDR-TB treatment ***			648

TB/HIV 2014	Number	(%)
TB patients with known HIV status	10 927	(69)
HIV-positive TB patients	312	(3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)	281	(90)
HIV-positive TB patients on antiretroviral therapy (ART)	278	(89)
HIV-positive people screened for TB	316
HIV-positive people provided with IPT	158

Treatment success rate and cohort size	(%)	Cohort
New and relapse cases registered in 2013	(85)	15 188
Previously treated cases, excluding relapse, registered in 2013	(45)	925
HIV-positive TB cases, all types, registered in 2013	(58)	250
RR-/MDR-TB cases started on second-line treatment in 2012	(34)	638
XDR-TB cases started on second-line treatment in 2012	(7)	41

Laboratories 2014
Smear (per 100 000 population)	0.5
Culture (per 5 million population)	23.2
Drug susceptibility testing (per 5 million population)	11.2
Sites performing Xpert MTB/RIF	3
Is second-line drug susceptibility testing available?	Yes, in country

Financing TB control 2015
National TB programme budget (US$ millions)	18
% Funded domestically	15%
% Funded internationally	67%
% Unfunded	18%

* Ranges represent uncertainty intervals

** Includes cases with unknown previous TB treatment history

*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having

RR-/MDR-TB